UK Bags More COVID-19 Vaccines And Backs J&J, Novavax Trials
Deal For 90 Million Doses
With the Janssen and Novavax deals, the UK has now secured access to six different candidates across four different vaccine types.

With the Janssen and Novavax deals, the UK has now secured access to six different candidates across four different vaccine types.